首页> 美国卫生研究院文献>Human Vaccines Immunotherapeutics >A Phase 4 multicentre randomized single-blind clinical trial to evaluate the immunogenicity of the live attenuated oral rotavirus vaccine (116E) ROTAVAC® administered simultaneously with or without the buffering agent in healthy infants in India

【2h】

A Phase 4 multicentre randomized single-blind clinical trial to evaluate the immunogenicity of the live attenuated oral rotavirus vaccine (116E) ROTAVAC® administered simultaneously with or without the buffering agent in healthy infants in India

机译：在印度的健康婴儿中与缓冲液同时使用或不联合使用时联合使用或不使用缓冲剂的口服减毒活轮状轮状病毒疫苗（116E）ROTAVAC®的第4期多中心随机单盲临床试验旨在评估其免疫原性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Human Vaccines Immunotherapeutics
作者
Raches Ella; Radhika Bobba; Sanjay Muralidhar; Sudhir Babji; Krishna Mohan Vadrevu; Maharaj Kishan Bhan;
展开▼
作者单位

展开▼
年(卷),期 2018(14),7
年度 2018
页码 1791–1799
总页数 9
原文格式 PDF
正文语种
中图分类免疫学;
关键词

相似文献

外文文献

1. A Phase 4, multicentre, randomized, single-blind clinical trial to evaluate the immunogenicity of the live, attenuated, oral rotavirus vaccine (116E), ROTAVAC (R), administered simultaneously with or without the buffering agent in healthy infants in India [J] . Ella Raches, Bobba Radhika, Muralidhar Sanjay, Human vaccines & immunotherapeutics. . 2018,第7期

机译：阶段4，多期式，随机，单盲临床试验，以评估与印度健康婴儿在健康婴儿的缓冲剂同时施用的活性，减毒，口腔瓣疫苗（116e），rotavac（R）的免疫原性
2. A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC (R) in comparison with a licensed rotavirus vaccine in healthy infants [J] . Vaccine . 2019,第31期

机译：随机开放标记的非劣级阶段4临床试验，以评估活性，减毒，口服轮状病毒疫苗，Rotavac（R）的免疫原性和安全性与健康婴儿的持牌轮状病毒疫苗相比
3. A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial. [J] . Bhandari N, Sharma P, Taneja S The Journal of Infectious Diseases . 2009,第3期

机译：婴幼儿减毒口服轮状病毒活疫苗116E的剂量递增安全性和免疫原性研究：一项随机，双盲，安慰剂对照试验。
4. A double-blind, randomized phase II trial of thesafety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adults [C] . Shelly A. McNeil, Scott A. Halperin, Joanne M. Langley, Lancefield International Symposium on Streptococci and Streptococcal Diseases . 2006

机译：一种双盲，随机期II试验，对健康成人的26岁的26岁群体的疫苗疫苗
5. Diarrheal Etiology and Impact of Coinfections on Rotavirus Vaccine Efficacy Estimates in a Clinical Trial of a Monovalent Human–Bovine (116E) Oral Rotavirus Vaccine Rotavac India [O] . Ira Praharaj, James A Platts-Mills, Sunita Taneja, -1

机译：腹泻病因学和合并感染对单价人牛（116E）口服轮状病毒疫苗的临床试验中轮状病毒疫苗效力估计的影响印度Rotavac
6. Immunogenicity of a live-attenuated human rotavirus RIX4414 vaccine with or without buffering agent [O] . Angkool Kerdpanich, Kulkanya Chokephaibulkit, Veerachai Watanaveeradej, 2010

机译：具有或不具有缓冲剂的活衰减人轮状病毒rix4414疫苗的免疫原性
7. Randomized Double-Blind Phase III Pivotal Field Trial of the Comparative Immunogenicity Safety and Tolerability of Two Yellow Fever 17D Vaccines (ARILVAX(Trademark) and YF-VAX(Trademark)) in Healthy Infants and Children in Peru [R] . Belmusto-Worn, V. E. , Sanchez, J. L. , McCarthy, K. , 2004

机译：秘鲁健康婴儿和儿童两种黄热病17D疫苗（aRILVaX（商标）和YF-VaX（商标））的比较免疫原性安全性和耐受性的随机双盲III期关键现场试验

A Phase 4 multicentre randomized single-blind clinical trial to evaluate the immunogenicity of the live attenuated oral rotavirus vaccine (116E) ROTAVAC® administered simultaneously with or without the buffering agent in healthy infants in India

著录项

相似文献

相关主题

期刊订阅